{"id":510,"kind":"story","title":"Where Software Founders Fit in the AI Drug Discovery Startup Boom","url":"https://www.wsj.com/articles/manas-ai-drug-discovery-reid-hoffman-93a6c023","host":"wsj.com","by":"mrlatte","score":1,"comments":0,"editorial_comments":0,"time":"2026-06-26T09:00:00.000Z","origin":"archive","language":{"source":"ko","reading":"en","translated":true},"summary":["Reid Hoffman and Siddhartha Mukherji launched Manas AI, an AI drug discovery startup, with a $24.6 million seed round.","It's a small amount compared to other companies raising $1.3 billion.","Software founders without biotech backgrounds should focus on the underlying platform and data layers rather than competing directly in drug creation.","If aiming to reduce researchers' time, confirm actual demand and work with colleagues who have biotech expertise."],"discussion":"https://startupxo.com/en/510/","markdown":"https://startupxo.com/en/510.md","api":"https://startupxo.com/api/v1/item.json?id=510&lang=en","text":null,"edited":null,"sources":[],"thread":[]}